American Joint Committee on Cancer Prognostic Factors Consensus Conference: Colorectal Working Group.

CDX2 as a Prognostic Biomarker in Stage II and Stage III Colon Cancer. N Engl J Med (2016) 8.53

Revised TN categorization for colon cancer based on national survival outcomes data. J Clin Oncol (2009) 4.09

Systemic treatment of colorectal cancer. Gastroenterology (2008) 2.62

Revised tumor and node categorization for rectal cancer based on surveillance, epidemiology, and end results and rectal pooled analysis outcomes. J Clin Oncol (2009) 2.47

Adjuvant Therapy for Stage II and III Colon Cancer: Consensus Report of the International Society of Gastrointestinal Oncology. Gastrointest Cancer Res (2007) 1.66

Mucinous histology predicts for poor response rate and overall survival of patients with colorectal cancer and treated with first-line oxaliplatin- and/or irinotecan-based chemotherapy. Br J Cancer (2009) 1.48

Are 12 nodes needed to accurately stage T1 and T2 colon cancers? Dig Dis Sci (2008) 1.44

Is occult lymph node disease in colorectal cancer patients clinically significant? A review of the relevant literature. J Mol Diagn (2007) 1.35

Distinct molecular patterns based on proximal and distal sporadic colorectal cancer: arguments for different mechanisms in the tumorigenesis. Int J Colorectal Dis (2006) 1.32

Lymphovascular invasion in colorectal cancer: an interobserver variability study. Am J Surg Pathol (2008) 1.21

Tumor markers in colorectal cancer, gastric cancer and gastrointestinal stromal cancers: European group on tumor markers 2014 guidelines update. Int J Cancer (2013) 1.21

Predictive capacity of three comorbidity indices in estimating mortality after surgery for colon cancer. J Clin Oncol (2009) 1.20

Prognostic effect of activated EGFR expression in human colon carcinomas: comparison with EGFR status. Br J Cancer (2009) 1.18

Analysis of the seventh edition of American Joint Committee on colon cancer staging. Int J Colorectal Dis (2011) 1.17

Invasive front of colorectal cancer: dynamic interface of pro-/anti-tumor factors. World J Gastroenterol (2009) 1.17

Decreased levels of plasma adiponectin associated with increased risk of colorectal cancer. World J Gastroenterol (2010) 1.17

Prospective, controlled, randomized study of intraoperative colonic lavage versus stent placement in obstructive left-sided colonic cancer. World J Surg (2011) 1.17

The total mesorectal excision specimen for rectal cancer: a review of its pathological assessment. J Clin Pathol (2006) 1.17

Prognostic significance and molecular associations of tumor growth pattern in colorectal cancer. Ann Surg Oncol (2011) 1.16

Early postoperative CEA level is a better prognostic indicator than is preoperative CEA level in predicting prognosis of patients with curable colorectal cancer. Int J Colorectal Dis (2011) 1.09

High-grade tumor differentiation is an indicator of poor prognosis in African Americans with colonic adenocarcinomas. Cancer (2005) 1.09

Prognostic impact of bim, puma, and noxa expression in human colon carcinomas. Clin Cancer Res (2008) 1.08

The prognostic factors of stage IV colorectal cancer and assessment of proper treatment according to the patient's status. Int J Colorectal Dis (2007) 1.05

Independent prognostic value of fascin immunoreactivity in stage III-IV colonic adenocarcinoma. Br J Cancer (2007) 1.04

Desmoplasia measured by computer assisted image analysis: an independent prognostic marker in colorectal carcinoma. J Clin Pathol (2005) 1.04

Overall expression of beta-catenin outperforms its nuclear accumulation in predicting outcomes of colorectal cancers. World J Gastroenterol (2008) 1.03

Effect of comorbidity and body mass index on the survival of African-American and Caucasian patients with colon cancer. Cancer (2009) 1.03

Prognostic impact of Beclin 1, p62/sequestosome 1 and LC3 protein expression in colon carcinomas from patients receiving 5-fluorouracil as adjuvant chemotherapy. Cancer Biol Ther (2012) 1.01

ErbB family immunohistochemical expression in colorectal cancer patients with higher risk of recurrence after radical surgery. Int J Colorectal Dis (2009) 0.99

Model-based prediction of defective DNA mismatch repair using clinicopathological variables in sporadic colon cancer patients. Cancer (2010) 0.98

Survival rates for stage II colon cancer patients treated with or without chemotherapy in a population-based setting. Int J Colorectal Dis (2007) 0.96

Prognostic evaluation and review of immunohistochemically detected disseminated tumor cells in peritumoral lymph nodes of patients with pN0 colorectal cancer. Int J Colorectal Dis (2004) 0.94

Clinicopathologic characteristics, surgical treatment and outcomes for splenic flexure colon cancer. Cancer Res Treat (2010) 0.93

Lymphatic vessel invasion detected by monoclonal antibody D2-40 as a predictor of lymph node metastasis in T1 colorectal cancer. Int J Colorectal Dis (2009) 0.93

Deletion of chromosome 4q predicts outcome in stage II colon cancer patients. Cell Oncol (Dordr) (2011) 0.92

Factors affecting lymph node yield from patients undergoing colectomy for cancer. Int J Colorectal Dis (2011) 0.92

ABCG5-positivity in tumor buds is an indicator of poor prognosis in node-negative colorectal cancer patients. World J Gastroenterol (2010) 0.91

Increased plasma levels of 8-hydroxydeoxyguanosine are associated with development of colorectal tumors. J Clin Biochem Nutr (2010) 0.90

Role of biological markers in the clinical outcome of colon cancer. Br J Cancer (2002) 0.90

Ki-ras gene mutations, LOH of the APC and DCC genes, and microsatellite instability in primary colorectal carcinoma are not associated with micrometastases in pericolonic lymph nodes or with patients' survival. J Clin Pathol (2004) 0.90

Thymidylate synthase expression and prognosis of patients with gastrointestinal cancers receiving adjuvant chemotherapy: a review. Langenbecks Arch Surg (2004) 0.89

Evaluating the quality of colorectal cancer care in the state of Florida: results from the Florida Initiative for Quality Cancer Care. J Oncol Pract (2012) 0.89

Is adjuvant chemotherapy beneficial to high risk stage II colon cancer? Analysis in a single institute. Int J Colorectal Dis (2009) 0.89

Cytokeratins and carcinoembryonic antigen in diagnosis, staging and prognosis of colorectal adenocarcinoma. World J Gastroenterol (2005) 0.89

Impact of molecular alterations and targeted therapy in appendiceal adenocarcinomas. Oncologist (2013) 0.89

Computed tomography and magnetic resonance imaging evaluation of lymph node metastasis in early colorectal cancer. World J Gastroenterol (2015) 0.89

Mucinous adenocarcinomas with intra-abdominal dissemination: a review of current therapy. Oncologist (2010) 0.88

Evaluation of four comorbidity indices and Charlson comorbidity index adjustment for colorectal cancer patients. Int J Colorectal Dis (2014) 0.88

Colorectal cancer tumour markers and biomarkers: Recent therapeutic advances. World J Gastroenterol (2016) 0.87

Persistent high postoperative carcinoembryonic antigen in colorectal cancer patients--is it important? Clinics (Sao Paulo) (2009) 0.87

The clinicopathological features of colorectal mucinous adenocarcinoma and a therapeutic strategy for the disease. World J Surg Oncol (2012) 0.86

Elevated preoperative carcinoembryonic antigen (CEA) and Ki67 is predictor of decreased survival in IIA stage colon cancer. World J Surg (2013) 0.86

Prognostic stratification of colorectal cancer patients: current perspectives. Cancer Manag Res (2014) 0.85

Review of histopathological and molecular prognostic features in colorectal cancer. Cancers (Basel) (2011) 0.85

Mucinous adenocarcinoma of the rectum: a poor candidate for neo-adjuvant chemoradiation? J Gastrointest Oncol (2014) 0.85

The impact on clinical outcome of high prevalence of diabetes mellitus in Taiwanese patients with colorectal cancer. World J Surg Oncol (2012) 0.85

Histopathological features predict metastatic potential in locally advanced colon carcinomas. BMC Cancer (2015) 0.85

Individualized Cutoff Value of the Preoperative Carcinoembryonic Antigen Level is Necessary for Optimal Use as a Prognostic Marker. Ann Coloproctol (2013) 0.85

Id-1: regulator of EGFR and VEGF and potential target for colorectal cancer therapy. J Exp Clin Cancer Res (2008) 0.84

Long-term follow-up of local rectal cancer surgery by transanal endoscopic microsurgery. World J Surg (2008) 0.84

Tumor budding as a risk factor of lymph node metastasis in submucosal invasive T1 colorectal carcinoma: a retrospective study. BMC Surg (2012) 0.84

Comparison of the predictive qualities of three prognostic models of colorectal cancer. Front Biosci (Elite Ed) (2010) 0.84

Analysis of albumin fatty acid binding capacity in patients with benign and malignant colorectal diseases using electron spin resonance (ESR) spectroscopy. Int J Colorectal Dis (2009) 0.83

Assessment of the prognostic factors for a local recurrence of rectal cancer: the utility of preoperative MR imaging. Korean J Radiol (2005) 0.83

Assessment of Serosal Invasion and Criteria for the Classification of Pathological (p) T4 Staging in Colorectal Carcinoma: Confusions, Controversies and Criticisms. Cancers (Basel) (2011) 0.83

Clinical presentation predicts the outcome of patients with colon cancer. World J Gastrointest Surg (2013) 0.82

Joint prognostic effect of obesity and chronic systemic inflammation in patients with metastatic colorectal cancer. Cancer (2015) 0.82

New insights into the role of age and carcinoembryonic antigen in the prognosis of colorectal cancer. Br J Cancer (2007) 0.81

Florida Initiative for Quality Cancer Care: improvements on colorectal cancer quality of care indicators during a 3-year interval. J Am Coll Surg (2013) 0.81

Clinical significance of lymph vessel density in T3 colorectal carcinoma. Int J Colorectal Dis (2012) 0.81

3'-UTR Polymorphisms in the MiRNA Machinery Genes DROSHA, DICER1, RAN, and XPO5 Are Associated with Colorectal Cancer Risk in a Korean Population. PLoS One (2015) 0.80

Carbohydrate antigen 19-9 is a valuable prognostic factor in colorectal cancer patients with normal levels of carcinoembryonic antigen and may help predict lung metastasis. Int J Colorectal Dis (2012) 0.80

[Risk factors for lymphatic metastasis from pT1 colorectal adenocarcinoma]. Pathologe (2003) 0.80

Hepatic resection in stage IV colorectal cancer: prognostic predictors of outcome. Int J Colorectal Dis (2004) 0.80

Magnetic resonance imaging (MRI)-based indication for neoadjuvant treatment of rectal carcinoma and the surrogate endpoint CRM status. Int J Colorectal Dis (2008) 0.80

Preoperative carcinoembryonic antigen and prognosis of colorectal cancer. An independent prognostic factor still reliable. Int Surg (2015) 0.79

Poor survival in stage IIB/C (T4N0) compared to stage IIIA (T1-2 N1, T1N2a) colon cancer persists even after adjusting for adequate lymph nodes retrieved and receipt of adjuvant chemotherapy. BMC Cancer (2016) 0.79

The serum level of carcinoembryonic antigen in drainage venous blood is not a sensitive predictor of metachronous hepatic metastasis for patients with colorectal cancer. Surg Today (2010) 0.79

Serum exosomal miR-4772-3p is a predictor of tumor recurrence in stage II and III colon cancer. Oncotarget (2016) 0.78

Factors predicting worse prognosis in patients affected by pT3 N0 colon cancer: long-term results of a monocentric series of 137 radically resected patients in a 5-year period. Int J Colorectal Dis (2012) 0.78

Should a colonoscopy be recommended for healthy individuals with increased carcinoembryonic antigen levels? A case-control study. Dig Dis Sci (2011) 0.77

Expression of Folate Pathway Genes in Stage III Colorectal Cancer Correlates with Recurrence Status Following Adjuvant Bolus 5-FU-Based Chemotherapy. Mol Med (2015) 0.77

hERG1 positivity and Glut-1 negativity identifies high-risk TNM stage I and II colorectal cancer patients, regardless of adjuvant chemotherapy. Onco Targets Ther (2016) 0.77

Polyp surveillance after surgery for colorectal cancer. Int J Colorectal Dis (2012) 0.76

Prognostic impact of membranous ATP-binding cassette Sub-family G member 2 expression in patients with colorectal carcinoma after surgical resection. Cancer Biol Ther (2015) 0.76

Survival after surgical treatment of cancer of the rectum. Langenbecks Arch Surg (2004) 0.75

NCAPH plays important roles in human colon cancer. Cell Death Dis (2017) 0.75

Evaluation of EphA2 and EphB4 as Targets for Image-Guided Colorectal Cancer Surgery. Int J Mol Sci (2017) 0.75

Association of pretreatment serum carcinoembryonic antigen levels with chemoradiation-induced downstaging and downsizing of rectal cancer. Mol Clin Oncol (2016) 0.75

Prognostic value of loss of heterozygosity and sub-cellular localization of SMAD4 varies with tumor stage in colorectal cancer. Oncotarget (2017) 0.75

Rectal adenocarcinoma: proposal for a model based on pretreatment prognostic factors. P R Health Sci J (2012) 0.75

Tumor micrometastases in mesorectal lymph nodes and their clinical significance in patients with rectal caner. World J Gastroenterol (2004) 0.75

Relationship between indoleamine 2,3-dioxygenase activity and lymphatic invasion propensity of colorectal carcinoma. World J Gastroenterol (2016) 0.75

Role of blood tumor markers in predicting metastasis and local recurrence after curative resection of colon cancer. Int J Clin Exp Med (2015) 0.75

Angiogenesis and dendritic cell density are not correlated with metachronous distant metastasis in curatively operated rectal cancer. Int J Colorectal Dis (2003) 0.75

Monitoring the treatment outcome in endometrial cancer patients by CEA and TATI. Tumour Biol (2016) 0.75

Histopathology and enhanced detection of tumor invasion of peritoneal membranes. PLoS One (2017) 0.75

Measurement of the Nucleus Area and Nucleus/Cytoplasm and Mitochondria/Nucleus Ratios in Human Colon Tissues by Dual-Colour Two-Photon Microscopy Imaging. Sci Rep (2015) 0.75

Local massive venous invasion in colorectal cancer: CT-pathological correlation and its clinical implication. Br J Radiol (2015) 0.75

Image analysis-derived metrics of histomorphological complexity predicts prognosis and treatment response in stage II-III colon cancer. Sci Rep (2016) 0.75

The Vienna classification of gastrointestinal epithelial neoplasia. Gut (2000) 9.39

Prognostic factors in colorectal cancer. College of American Pathologists Consensus Statement 1999. Arch Pathol Lab Med (2000) 5.68

Anastomotic integrity after operations for large-bowel cancer: a multicentre study. Br Med J (1980) 4.63

Mixed hyperplastic adenomatous polyps/serrated adenomas. A distinct form of colorectal neoplasia. Am J Surg Pathol (1990) 3.89

Local recurrence following 'curative' surgery for large bowel cancer: I. The overall picture. Br J Surg (1984) 3.82

Haematogenous metastatic patterns in colonic carcinoma: an analysis of 1541 necropsies. J Pathol (1986) 2.93

Surgeon-related variables and the clinical trial. Lancet (1978) 2.86

Malignant large bowel obstruction. Br J Surg (1985) 2.62

Histopathology reporting in large bowel cancer. J Clin Pathol (1981) 2.43

Determinants of black/white differences in colon cancer survival. J Natl Cancer Inst (1995) 2.36

American Joint Committee on Cancer prognostic factors consensus conference. Cancer (1999) 2.02

Survival after primary and after staged resection for large bowel obstruction caused by cancer. Br J Surg (1974) 1.64

A double-blind trial of the clinical effects of pulsed electromagnetic fields in osteoarthritis. J Rheumatol (1993) 1.62

The association between melanoma, lymphoma, and other primary neoplasms. Arch Surg (1995) 1.59

The pattern of cell proliferation in neoplastic and nonneoplastic lesions of ulcerative colitis. Cancer (1996) 1.57

Gastroduodenal rebleeding on cimetidine. Lancet (1977) 1.54

Identification of preventable trauma deaths: confounded inquiries? J Trauma (1992) 1.52

Local recurrence following 'curative' surgery for large bowel cancer: II. The rectum and rectosigmoid. Br J Surg (1984) 1.51

Large-bowel obstruction caused by cancer: a prospective study. Br Med J (1979) 1.51

Current problems in the measurement of gastrin release. A reproducible measure of physiological gastrin release. Postgrad Med J (1976) 1.42

The future of prognostic factors in outcome prediction for patients with cancer. Cancer (1992) 1.39

Prediction of outcome after curative resection for large bowel cancer. Lancet (1986) 1.38

Aggressiveness of colon carcinoma in blacks and whites. National Cancer Institute Black/White Cancer Survival Study Group. Cancer Epidemiol Biomarkers Prev (1997) 1.37

Development, progression, and androgen-dependence of prostate tumors in probasin-large T antigen transgenic mice: a model for prostate cancer. Lab Invest (1998) 1.35

The molecular biology of esophageal and gastric cancer and their precursors: oncogenes, tumor suppressor genes, and growth factors. Hum Pathol (1994) 1.30

Colorectal adenomas containing invasive carcinoma. Pathologic assessment of lymph node metastatic potential. Cancer (1989) 1.30

Influence of tumour site on presentation, management and subsequent outcome in large bowel cancer. Br J Surg (1986) 1.20

College of American Pathologists Conference XXXV: solid tumor prognostic factors-which, how and so what? Summary document and recommendations for implementation. Cancer Committee and Conference Participants. Arch Pathol Lab Med (2000) 1.17

Large bowel cancer: surgical pathology and its relationship to survival. Br J Surg (1984) 1.15

Adenoma-carcinoid tumors of the colon. Arch Pathol Lab Med (1998) 1.13

Southwest Oncology Group study S0413: a phase II trial of lapatinib (GW572016) as first-line therapy in patients with advanced or metastatic gastric cancer. Ann Oncol (2011) 1.11

College of American Pathologists Conference XXVI on clinical relevance of prognostic markers in solid tumors. Summary. Members of the Cancer Committee. Arch Pathol Lab Med (1995) 1.10

Immunohistochemical analysis of Bcl-2 family proteins in adenocarcinomas of the stomach. Am J Pathol (1996) 1.08

Medullary carcinoma of the thyroid gland. Clinical, pathological, and immunohistochemical features with review of the literature. Am J Surg Pathol (1985) 1.08

Covering stoma for elective anterior resection of the rectum: an outmoded operation? Am J Surg (1984) 1.04

Subclavian vein cannulation equipment. The state of the art. J R Coll Surg Edinb (1974) 1.03

Updated recommendations from the Canadian National Consensus Meeting on HER2/neu testing in breast cancer. Curr Oncol (2007) 1.01

Detection of human papillomavirus in esophageal squamous cell carcinoma. Cancer (1996) 1.00

Development, progression, and androgen-dependence of prostate tumors in probasin-large T antigen transgenic mice: a model for prostate cancer. Lab Invest (1998) 0.98

Serum immunoglobulins predict the extent of hepatic fibrosis in patients with chronic hepatitis C virus infection. J Viral Hepat (2004) 0.98

Multifocal neoplasia involving the colon and appendix in ulcerative colitis: pathological and molecular features. Gastroenterology (1998) 0.97

College of American Pathologists Conference XXVI on clinical relevance of prognostic markers in solid tumors. Report of the Colorectal Cancer Working Group. Arch Pathol Lab Med (1995) 0.97

p53 immunoreactivity and single-strand conformational polymorphism analysis often fail to predict p53 mutational status. Mod Pathol (1999) 0.96

Esophageal heterotopic pancreas presenting as an inflammatory mass. Dig Dis Sci (1995) 0.95

COTA (colon-ovarian tumor antigen). An immunohistochemical study. Am J Clin Pathol (1986) 0.95

Local tumor recurrence after curative resection for rectal cancer. A ten-hospital review. Dis Colon Rectum (1987) 0.94

Amplification and expression of the cyclin D1 gene in anal and esophageal squamous cell carcinomas. Hum Pathol (1997) 0.94

Expression of mRNA for epidermal growth factor, transforming growth factor-alpha and their receptor in human prostate tissue and cell lines. Mol Cell Biochem (1993) 0.94

Large bowel cancer: the effect of perioperative blood transfusion on outcome. Ann R Coll Surg Engl (1990) 0.93

Does vasoactive intestinal polypeptide mediate the pathophysiology of bowel obstruction? Am J Surg (1989) 0.92

Hepatic regeneration in humans with various liver disease as assessed by Ki-67 staining of formalin-fixed paraffin-embedded liver tissue. Liver (1997) 0.92

Proceedings: Effects of salbutamol on gastric acid secretion and gastrin liberation after feeding in conscious Heidenhain pouch dogs. Br J Pharmacol (1974) 0.92

Interinstitutional database for comparison of performance in lung fine-needle aspiration cytology. A College of American Pathologists Q-Probe Study of 5264 cases with histologic correlation. Arch Pathol Lab Med (1992) 0.92

Survey of residents' attitudes toward reform of work hours. Arch Surg (1990) 0.90

Severe gastroparesis diabeticorum in a young patient with insulin dependent diabetes. BMJ (1995) 0.90

Inhibition of intrinsic factor secretion by cimetidine. Br Med J (1978) 0.90

Inhibition of VIP-stimulated ion transport by a novel Y-receptor phenotype in rabbit distal colon. Am J Physiol (1993) 0.89

Lymphatic distribution of the stomach in normal, inflammatory, hyperplastic, and neoplastic tissue. Gastroenterology (1987) 0.89

Red for danger: blood transfusion and colorectal cancer. Br Med J (Clin Res Ed) (1985) 0.89

Behavioral disturbances in children after trauma. J Trauma (1991) 0.88

Risks of surgery for upper gastrointestinal hemorrhage: 1972 versus 1982. Am J Surg (1985) 0.88

Acute perforated diverticulitis: primary resection and anastomosis? Conn Med (1991) 0.88

Carboxyl ester lipase activity in milk prevents fat-derived intestinal injury in neonatal mice. Am J Physiol (1999) 0.88

Proceedings: Salbutamol: effect on acid secretion and plasma gastrin in human subjects. Br J Surg (1975) 0.88

Differential sensitivities of E6 type-specific and L1 consensus primers in the detection of human papillomavirus in anal carcinoma. Mod Pathol (1995) 0.87

Large bowel obstruction: survival after curative resection for carcinoma. Proc R Soc Med (1973) 0.87

Drunk drivers and medical and social injury. N Engl J Med (1987) 0.86

Primary resection and anastomosis for treatment of acute diverticulitis. Dis Colon Rectum (1989) 0.86

Gastric carcinoma in the young: a clinicopathological and immunohistochemical study. Am J Gastroenterol (1986) 0.85

Anatomic site distribution of colon cancer by race and other colon cancer risk factors. Dis Colon Rectum (1995) 0.84

A rational approach to parenteral nutrition. Br Med J (1976) 0.84

Microsatellite instability and K-ras mutations in patients with ulcerative colitis. Hum Pathol (2000) 0.83

A germline hMSH2 alteration is unrelated to colonic microsatellite instability in patients with ulcerative colitis. Hum Pathol (1999) 0.83

A unique basal pattern of p53 expression in ulcerative colitis is associated with mutation in the p53 gene. Histopathology (2001) 0.83

The relationship of human papillomaviruses to anorectal neoplasia. Cancer (1992) 0.83

Proceedings: The effect of cimetidine, a histamine H2 antagonist, on gastric acid and intrinsic factor secretion during pentagastrin infusion. Br J Surg (1976) 0.82

Immunoreactivity of tumor-associated glycoprotein (TAG-72) in normal, hyperplastic, and neoplastic colon. Hum Pathol (1989) 0.82

Tumors of dysgenetic gonads (gonadoblastoma): ultrastructural and steroidogenic aspects. Cancer (1974) 0.82

Large colorectal polyps: colonoscopy, pathology, and management. Am J Gastroenterol (1989) 0.81

Colorectal polyps: pathologic diagnosis and clinical significance. CA Cancer J Clin (1985) 0.81

The relationship of human papillomavirus to proliferation and ploidy in carcinoma of the anus. Cancer (1995) 0.81

The effect of highly selective vagotomy on the relationship between gastric mucosal blood flow and acid secretion in man. Br J Surg (1978) 0.81

Gastrointestinal polyps. Mod Pathol (1989) 0.81

Testing for her2 in breast cancer: current pathology challenges faced in Canada. Curr Oncol (2012) 0.81

Regional blood flow and water content of the obstructed small intestine. Arch Surg (1985) 0.81

Liver regeneration and the effect of exogenous putrescine on regenerative activity after partial hepatectomy in cirrhotic rats. Hepatology (1992) 0.81

Malignant mixed müllerian tumor of the extraovarian secondary müllerian system. Report of two cases and review of the English literature. Arch Pathol Lab Med (1995) 0.80

Vascular responsiveness in obstructed gut. Dis Colon Rectum (1991) 0.79

Effect of streptozotocin diabetes on development of nitrosamine-induced pancreatic carcinoma when diabetes induction occurs after nitrosamine exposure. Carcinogenesis (1993) 0.79

Hepatitis-associated, antigen-induced lymphocyte transformation in chronic hepatic disease. Gut (1972) 0.79

Sensitivity of colon blood flow to changing hemodynamics events. Curr Surg (1985) 0.79

Proceedings: Salbutamol: inhibition of gastric ulceration in the rat. Br J Surg (1975) 0.79

Molecular biology and the pathologist. General principles and applications. Arch Pathol Lab Med (1987) 0.78

Regenerative lesions in ulcerative colitis are characterized by microsatellite mutation. Genes Chromosomes Cancer (1997) 0.78

Functioning oncocytic islet-cell carcinoma. Report of a case with electron-microscopic and immunohistochemical confirmation. Am J Surg Pathol (1985) 0.78

Cimetidine and pancreatic function. Lancet (1978) 0.78

Neuropeptide Y inhibition of vasoactive intestinal polypeptide-stimulated ion transport in the rabbit distal colon. Arch Surg (1990) 0.77

Low back injury in industry: the value of a recovery program. Conn Med (1989) 0.77

Oncogenes, suppressor genes, and carcinogenesis. Hum Pathol (1987) 0.77

Staging of colorectal cancer. Int J Colorectal Dis (1987) 0.76